The global Ophthalmic Anti-infective Preparations market was valued at US$ 1468.1 million in 2023 and is anticipated to reach US$ 1851.5 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.

Ophthalmic Anti-infective Preparations Market

Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Ophthalmic Anti-infective Preparations, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Anti-infective Preparations.

Report Scope

The Ophthalmic Anti-infective Preparations market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ophthalmic Anti-infective Preparations market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ophthalmic Anti-infective Preparations manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Ophthalmic Anti-infective Preparations Market Report

Report Metric	Details
Report Name	Ophthalmic Anti-infective Preparations Market
Accounted market size in 2023	US$ 1468.1 million
Forecasted market size in 2030	US$ 1851.5 million
CAGR	3.3%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Antibacterial Antiviral Antifungal Anti-parasitic Others
Segment by Application	Hospital Use Clinic Use Household Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Allergan PLC, Bayer AG, F. Hoffmann-La Roche AG, Johnson and Johnson Vision Care Inc, Kyowa Kirin Co., Ltd, Novartis International AG, Pfizer, Inc., Regeneron Pharmaceuticals, Inc., Santen Pharmaceuticals Co., Ltd., Shire PLC, Bausch Health, Lupin Pharmaceuticals, Apotex, Akorn
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ophthalmic Anti-infective Preparations manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ophthalmic Anti-infective Preparations in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Ophthalmic Anti-infective Preparations Market growing?

Ans: The Ophthalmic Anti-infective Preparations Market witnessing a CAGR of 3.3% during the forecast period 2024-2030.

What is the Ophthalmic Anti-infective Preparations Market size in 2030?

Ans: The Ophthalmic Anti-infective Preparations Market size in 2030 will be US$ 1851.5 million.

Who are the main players in the Ophthalmic Anti-infective Preparations Market report?

Ans: The main players in the Ophthalmic Anti-infective Preparations Market are Allergan PLC, Bayer AG, F. Hoffmann-La Roche AG, Johnson and Johnson Vision Care Inc, Kyowa Kirin Co., Ltd, Novartis International AG, Pfizer, Inc., Regeneron Pharmaceuticals, Inc., Santen Pharmaceuticals Co., Ltd., Shire PLC, Bausch Health, Lupin Pharmaceuticals, Apotex, Akorn

What are the Application segmentation covered in the Ophthalmic Anti-infective Preparations Market report?

Ans: The Applications covered in the Ophthalmic Anti-infective Preparations Market report are Hospital Use, Clinic Use, Household, Other

What are the Type segmentation covered in the Ophthalmic Anti-infective Preparations Market report?

Ans: The Types covered in the Ophthalmic Anti-infective Preparations Market report are Antibacterial, Antiviral, Antifungal, Anti-parasitic, Others

1 Ophthalmic Anti-infective Preparations Market Overview

1.1 Product Overview and Scope of Ophthalmic Anti-infective Preparations

1.2 Ophthalmic Anti-infective Preparations Segment by Type

1.2.1 Global Ophthalmic Anti-infective Preparations Market Value Comparison by Type (2024-2030)

1.2.2 Antibacterial

1.2.3 Antiviral

1.2.4 Antifungal

1.2.5 Anti-parasitic

1.2.6 Others

1.3 Ophthalmic Anti-infective Preparations Segment by Application

1.3.1 Global Ophthalmic Anti-infective Preparations Market Value by Application: (2024-2030)

1.3.2 Hospital Use

1.3.3 Clinic Use

1.3.4 Household

1.3.5 Other

1.4 Global Ophthalmic Anti-infective Preparations Market Size Estimates and Forecasts

1.4.1 Global Ophthalmic Anti-infective Preparations Revenue 2019-2030

1.4.2 Global Ophthalmic Anti-infective Preparations Sales 2019-2030

1.4.3 Global Ophthalmic Anti-infective Preparations Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Ophthalmic Anti-infective Preparations Market Competition by Manufacturers

2.1 Global Ophthalmic Anti-infective Preparations Sales Market Share by Manufacturers (2019-2024)

2.2 Global Ophthalmic Anti-infective Preparations Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Ophthalmic Anti-infective Preparations Average Price by Manufacturers (2019-2024)

2.4 Global Ophthalmic Anti-infective Preparations Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Ophthalmic Anti-infective Preparations, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Ophthalmic Anti-infective Preparations, Product Type & Application

2.7 Ophthalmic Anti-infective Preparations Market Competitive Situation and Trends

2.7.1 Ophthalmic Anti-infective Preparations Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Ophthalmic Anti-infective Preparations Players Market Share by Revenue

2.7.3 Global Ophthalmic Anti-infective Preparations Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Ophthalmic Anti-infective Preparations Retrospective Market Scenario by Region

3.1 Global Ophthalmic Anti-infective Preparations Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Ophthalmic Anti-infective Preparations Global Ophthalmic Anti-infective Preparations Sales by Region: 2019-2030

3.2.1 Global Ophthalmic Anti-infective Preparations Sales by Region: 2019-2024

3.2.2 Global Ophthalmic Anti-infective Preparations Sales by Region: 2025-2030

3.3 Global Ophthalmic Anti-infective Preparations Global Ophthalmic Anti-infective Preparations Revenue by Region: 2019-2030

3.3.1 Global Ophthalmic Anti-infective Preparations Revenue by Region: 2019-2024

3.3.2 Global Ophthalmic Anti-infective Preparations Revenue by Region: 2025-2030

3.4 North America Ophthalmic Anti-infective Preparations Market Facts & Figures by Country

3.4.1 North America Ophthalmic Anti-infective Preparations Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Ophthalmic Anti-infective Preparations Sales by Country (2019-2030)

3.4.3 North America Ophthalmic Anti-infective Preparations Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Ophthalmic Anti-infective Preparations Market Facts & Figures by Country

3.5.1 Europe Ophthalmic Anti-infective Preparations Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Ophthalmic Anti-infective Preparations Sales by Country (2019-2030)

3.5.3 Europe Ophthalmic Anti-infective Preparations Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Ophthalmic Anti-infective Preparations Market Facts & Figures by Country

3.6.1 Asia Pacific Ophthalmic Anti-infective Preparations Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Ophthalmic Anti-infective Preparations Sales by Country (2019-2030)

3.6.3 Asia Pacific Ophthalmic Anti-infective Preparations Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Ophthalmic Anti-infective Preparations Market Facts & Figures by Country

3.7.1 Latin America Ophthalmic Anti-infective Preparations Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Ophthalmic Anti-infective Preparations Sales by Country (2019-2030)

3.7.3 Latin America Ophthalmic Anti-infective Preparations Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Ophthalmic Anti-infective Preparations Market Facts & Figures by Country

3.8.1 Middle East and Africa Ophthalmic Anti-infective Preparations Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Ophthalmic Anti-infective Preparations Sales by Country (2019-2030)

3.8.3 Middle East and Africa Ophthalmic Anti-infective Preparations Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Ophthalmic Anti-infective Preparations Sales by Type (2019-2030)

4.1.1 Global Ophthalmic Anti-infective Preparations Sales by Type (2019-2024)

4.1.2 Global Ophthalmic Anti-infective Preparations Sales by Type (2025-2030)

4.1.3 Global Ophthalmic Anti-infective Preparations Sales Market Share by Type (2019-2030)

4.2 Global Ophthalmic Anti-infective Preparations Revenue by Type (2019-2030)

4.2.1 Global Ophthalmic Anti-infective Preparations Revenue by Type (2019-2024)

4.2.2 Global Ophthalmic Anti-infective Preparations Revenue by Type (2025-2030)

4.2.3 Global Ophthalmic Anti-infective Preparations Revenue Market Share by Type (2019-2030)

4.3 Global Ophthalmic Anti-infective Preparations Price by Type (2019-2030)

5 Segment by Application

5.1 Global Ophthalmic Anti-infective Preparations Sales by Application (2019-2030)

5.1.1 Global Ophthalmic Anti-infective Preparations Sales by Application (2019-2024)

5.1.2 Global Ophthalmic Anti-infective Preparations Sales by Application (2025-2030)

5.1.3 Global Ophthalmic Anti-infective Preparations Sales Market Share by Application (2019-2030)

5.2 Global Ophthalmic Anti-infective Preparations Revenue by Application (2019-2030)

5.2.1 Global Ophthalmic Anti-infective Preparations Revenue by Application (2019-2024)

5.2.2 Global Ophthalmic Anti-infective Preparations Revenue by Application (2025-2030)

5.2.3 Global Ophthalmic Anti-infective Preparations Revenue Market Share by Application (2019-2030)

5.3 Global Ophthalmic Anti-infective Preparations Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Allergan PLC

6.1.1 Allergan PLC Corporation Information

6.1.2 Allergan PLC Description and Business Overview

6.1.3 Allergan PLC Ophthalmic Anti-infective Preparations Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Allergan PLC Ophthalmic Anti-infective Preparations Product Portfolio

6.1.5 Allergan PLC Recent Developments/Updates

6.2 Bayer AG

6.2.1 Bayer AG Corporation Information

6.2.2 Bayer AG Description and Business Overview

6.2.3 Bayer AG Ophthalmic Anti-infective Preparations Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Bayer AG Ophthalmic Anti-infective Preparations Product Portfolio

6.2.5 Bayer AG Recent Developments/Updates

6.3 F. Hoffmann-La Roche AG

6.3.1 F. Hoffmann-La Roche AG Corporation Information

6.3.2 F. Hoffmann-La Roche AG Description and Business Overview

6.3.3 F. Hoffmann-La Roche AG Ophthalmic Anti-infective Preparations Sales, Revenue and Gross Margin (2019-2024)

6.3.4 F. Hoffmann-La Roche AG Ophthalmic Anti-infective Preparations Product Portfolio

6.3.5 F. Hoffmann-La Roche AG Recent Developments/Updates

6.4 Johnson and Johnson Vision Care Inc

6.4.1 Johnson and Johnson Vision Care Inc Corporation Information

6.4.2 Johnson and Johnson Vision Care Inc Description and Business Overview

6.4.3 Johnson and Johnson Vision Care Inc Ophthalmic Anti-infective Preparations Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Johnson and Johnson Vision Care Inc Ophthalmic Anti-infective Preparations Product Portfolio

6.4.5 Johnson and Johnson Vision Care Inc Recent Developments/Updates

6.5 Kyowa Kirin Co., Ltd

6.5.1 Kyowa Kirin Co., Ltd Corporation Information

6.5.2 Kyowa Kirin Co., Ltd Description and Business Overview

6.5.3 Kyowa Kirin Co., Ltd Ophthalmic Anti-infective Preparations Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Kyowa Kirin Co., Ltd Ophthalmic Anti-infective Preparations Product Portfolio

6.5.5 Kyowa Kirin Co., Ltd Recent Developments/Updates

6.6 Novartis International AG

6.6.1 Novartis International AG Corporation Information

6.6.2 Novartis International AG Description and Business Overview

6.6.3 Novartis International AG Ophthalmic Anti-infective Preparations Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Novartis International AG Ophthalmic Anti-infective Preparations Product Portfolio

6.6.5 Novartis International AG Recent Developments/Updates

6.7 Pfizer, Inc.

6.6.1 Pfizer, Inc. Corporation Information

6.6.2 Pfizer, Inc. Description and Business Overview

6.6.3 Pfizer, Inc. Ophthalmic Anti-infective Preparations Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Pfizer, Inc. Ophthalmic Anti-infective Preparations Product Portfolio

6.7.5 Pfizer, Inc. Recent Developments/Updates

6.8 Regeneron Pharmaceuticals, Inc.

6.8.1 Regeneron Pharmaceuticals, Inc. Corporation Information

6.8.2 Regeneron Pharmaceuticals, Inc. Description and Business Overview

6.8.3 Regeneron Pharmaceuticals, Inc. Ophthalmic Anti-infective Preparations Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Regeneron Pharmaceuticals, Inc. Ophthalmic Anti-infective Preparations Product Portfolio

6.8.5 Regeneron Pharmaceuticals, Inc. Recent Developments/Updates

6.9 Santen Pharmaceuticals Co., Ltd.

6.9.1 Santen Pharmaceuticals Co., Ltd. Corporation Information

6.9.2 Santen Pharmaceuticals Co., Ltd. Description and Business Overview

6.9.3 Santen Pharmaceuticals Co., Ltd. Ophthalmic Anti-infective Preparations Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Santen Pharmaceuticals Co., Ltd. Ophthalmic Anti-infective Preparations Product Portfolio

6.9.5 Santen Pharmaceuticals Co., Ltd. Recent Developments/Updates

6.10 Shire PLC

6.10.1 Shire PLC Corporation Information

6.10.2 Shire PLC Description and Business Overview

6.10.3 Shire PLC Ophthalmic Anti-infective Preparations Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Shire PLC Ophthalmic Anti-infective Preparations Product Portfolio

6.10.5 Shire PLC Recent Developments/Updates

6.11 Bausch Health

6.11.1 Bausch Health Corporation Information

6.11.2 Bausch Health Ophthalmic Anti-infective Preparations Description and Business Overview

6.11.3 Bausch Health Ophthalmic Anti-infective Preparations Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Bausch Health Ophthalmic Anti-infective Preparations Product Portfolio

6.11.5 Bausch Health Recent Developments/Updates

6.12 Lupin Pharmaceuticals

6.12.1 Lupin Pharmaceuticals Corporation Information

6.12.2 Lupin Pharmaceuticals Ophthalmic Anti-infective Preparations Description and Business Overview

6.12.3 Lupin Pharmaceuticals Ophthalmic Anti-infective Preparations Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Lupin Pharmaceuticals Ophthalmic Anti-infective Preparations Product Portfolio

6.12.5 Lupin Pharmaceuticals Recent Developments/Updates

6.13 Apotex

6.13.1 Apotex Corporation Information

6.13.2 Apotex Ophthalmic Anti-infective Preparations Description and Business Overview

6.13.3 Apotex Ophthalmic Anti-infective Preparations Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Apotex Ophthalmic Anti-infective Preparations Product Portfolio

6.13.5 Apotex Recent Developments/Updates

6.14 Akorn

6.14.1 Akorn Corporation Information

6.14.2 Akorn Ophthalmic Anti-infective Preparations Description and Business Overview

6.14.3 Akorn Ophthalmic Anti-infective Preparations Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Akorn Ophthalmic Anti-infective Preparations Product Portfolio

6.14.5 Akorn Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Ophthalmic Anti-infective Preparations Industry Chain Analysis

7.2 Ophthalmic Anti-infective Preparations Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Ophthalmic Anti-infective Preparations Production Mode & Process

7.4 Ophthalmic Anti-infective Preparations Sales and Marketing

7.4.1 Ophthalmic Anti-infective Preparations Sales Channels

7.4.2 Ophthalmic Anti-infective Preparations Distributors

7.5 Ophthalmic Anti-infective Preparations Customers

8 Ophthalmic Anti-infective Preparations Market Dynamics

8.1 Ophthalmic Anti-infective Preparations Industry Trends

8.2 Ophthalmic Anti-infective Preparations Market Drivers

8.3 Ophthalmic Anti-infective Preparations Market Challenges

8.4 Ophthalmic Anti-infective Preparations Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Allergan plc

Bayer

F. Hoffmann-La Roche AG

Johnson and Johnson Vision Care Inc.

Kyowa Kirin Co., Ltd.

Novartis International AG

Pfizer Inc

Regeneron Pharmaceuticals Inc

Santen Pharmaceuticals Co., Ltd.

Shire Plc

Bausch Health

Lupin Pharmaceuticals

Apotex

Akorn

List of Tables

Table 1. Global Ophthalmic Anti-infective Preparations Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Ophthalmic Anti-infective Preparations Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Ophthalmic Anti-infective Preparations Market Competitive Situation by Manufacturers in 2023

Table 4. Global Ophthalmic Anti-infective Preparations Sales (MT) of Key Manufacturers (2019-2024)

Table 5. Global Ophthalmic Anti-infective Preparations Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Ophthalmic Anti-infective Preparations Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Ophthalmic Anti-infective Preparations Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Ophthalmic Anti-infective Preparations Average Price (USD/MT) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Ophthalmic Anti-infective Preparations, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Ophthalmic Anti-infective Preparations, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Ophthalmic Anti-infective Preparations, Product Type & Application

Table 12. Global Key Manufacturers of Ophthalmic Anti-infective Preparations, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Ophthalmic Anti-infective Preparations by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Anti-infective Preparations as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Ophthalmic Anti-infective Preparations Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Ophthalmic Anti-infective Preparations Sales by Region (2019-2024) & (MT)

Table 18. Global Ophthalmic Anti-infective Preparations Sales Market Share by Region (2019-2024)

Table 19. Global Ophthalmic Anti-infective Preparations Sales by Region (2025-2030) & (MT)

Table 20. Global Ophthalmic Anti-infective Preparations Sales Market Share by Region (2025-2030)

Table 21. Global Ophthalmic Anti-infective Preparations Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Ophthalmic Anti-infective Preparations Revenue Market Share by Region (2019-2024)

Table 23. Global Ophthalmic Anti-infective Preparations Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Ophthalmic Anti-infective Preparations Revenue Market Share by Region (2025-2030)

Table 25. North America Ophthalmic Anti-infective Preparations Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Ophthalmic Anti-infective Preparations Sales by Country (2019-2024) & (MT)

Table 27. North America Ophthalmic Anti-infective Preparations Sales by Country (2025-2030) & (MT)

Table 28. North America Ophthalmic Anti-infective Preparations Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Ophthalmic Anti-infective Preparations Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Ophthalmic Anti-infective Preparations Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Ophthalmic Anti-infective Preparations Sales by Country (2019-2024) & (MT)

Table 32. Europe Ophthalmic Anti-infective Preparations Sales by Country (2025-2030) & (MT)

Table 33. Europe Ophthalmic Anti-infective Preparations Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Ophthalmic Anti-infective Preparations Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Ophthalmic Anti-infective Preparations Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Ophthalmic Anti-infective Preparations Sales by Region (2019-2024) & (MT)

Table 37. Asia Pacific Ophthalmic Anti-infective Preparations Sales by Region (2025-2030) & (MT)

Table 38. Asia Pacific Ophthalmic Anti-infective Preparations Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Ophthalmic Anti-infective Preparations Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Ophthalmic Anti-infective Preparations Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Ophthalmic Anti-infective Preparations Sales by Country (2019-2024) & (MT)

Table 42. Latin America Ophthalmic Anti-infective Preparations Sales by Country (2025-2030) & (MT)

Table 43. Latin America Ophthalmic Anti-infective Preparations Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Ophthalmic Anti-infective Preparations Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Ophthalmic Anti-infective Preparations Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Ophthalmic Anti-infective Preparations Sales by Country (2019-2024) & (MT)

Table 47. Middle East & Africa Ophthalmic Anti-infective Preparations Sales by Country (2025-2030) & (MT)

Table 48. Middle East & Africa Ophthalmic Anti-infective Preparations Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Ophthalmic Anti-infective Preparations Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Ophthalmic Anti-infective Preparations Sales (MT) by Type (2019-2024)

Table 51. Global Ophthalmic Anti-infective Preparations Sales (MT) by Type (2025-2030)

Table 52. Global Ophthalmic Anti-infective Preparations Sales Market Share by Type (2019-2024)

Table 53. Global Ophthalmic Anti-infective Preparations Sales Market Share by Type (2025-2030)

Table 54. Global Ophthalmic Anti-infective Preparations Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Ophthalmic Anti-infective Preparations Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Ophthalmic Anti-infective Preparations Revenue Market Share by Type (2019-2024)

Table 57. Global Ophthalmic Anti-infective Preparations Revenue Market Share by Type (2025-2030)

Table 58. Global Ophthalmic Anti-infective Preparations Price (USD/MT) by Type (2019-2024)

Table 59. Global Ophthalmic Anti-infective Preparations Price (USD/MT) by Type (2025-2030)

Table 60. Global Ophthalmic Anti-infective Preparations Sales (MT) by Application (2019-2024)

Table 61. Global Ophthalmic Anti-infective Preparations Sales (MT) by Application (2025-2030)

Table 62. Global Ophthalmic Anti-infective Preparations Sales Market Share by Application (2019-2024)

Table 63. Global Ophthalmic Anti-infective Preparations Sales Market Share by Application (2025-2030)

Table 64. Global Ophthalmic Anti-infective Preparations Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Ophthalmic Anti-infective Preparations Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Ophthalmic Anti-infective Preparations Revenue Market Share by Application (2019-2024)

Table 67. Global Ophthalmic Anti-infective Preparations Revenue Market Share by Application (2025-2030)

Table 68. Global Ophthalmic Anti-infective Preparations Price (USD/MT) by Application (2019-2024)

Table 69. Global Ophthalmic Anti-infective Preparations Price (USD/MT) by Application (2025-2030)

Table 70. Allergan PLC Corporation Information

Table 71. Allergan PLC Description and Business Overview

Table 72. Allergan PLC Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 73. Allergan PLC Ophthalmic Anti-infective Preparations Product

Table 74. Allergan PLC Recent Developments/Updates

Table 75. Bayer AG Corporation Information

Table 76. Bayer AG Description and Business Overview

Table 77. Bayer AG Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 78. Bayer AG Ophthalmic Anti-infective Preparations Product

Table 79. Bayer AG Recent Developments/Updates

Table 80. F. Hoffmann-La Roche AG Corporation Information

Table 81. F. Hoffmann-La Roche AG Description and Business Overview

Table 82. F. Hoffmann-La Roche AG Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 83. F. Hoffmann-La Roche AG Ophthalmic Anti-infective Preparations Product

Table 84. F. Hoffmann-La Roche AG Recent Developments/Updates

Table 85. Johnson and Johnson Vision Care Inc Corporation Information

Table 86. Johnson and Johnson Vision Care Inc Description and Business Overview

Table 87. Johnson and Johnson Vision Care Inc Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 88. Johnson and Johnson Vision Care Inc Ophthalmic Anti-infective Preparations Product

Table 89. Johnson and Johnson Vision Care Inc Recent Developments/Updates

Table 90. Kyowa Kirin Co., Ltd Corporation Information

Table 91. Kyowa Kirin Co., Ltd Description and Business Overview

Table 92. Kyowa Kirin Co., Ltd Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 93. Kyowa Kirin Co., Ltd Ophthalmic Anti-infective Preparations Product

Table 94. Kyowa Kirin Co., Ltd Recent Developments/Updates

Table 95. Novartis International AG Corporation Information

Table 96. Novartis International AG Description and Business Overview

Table 97. Novartis International AG Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 98. Novartis International AG Ophthalmic Anti-infective Preparations Product

Table 99. Novartis International AG Recent Developments/Updates

Table 100. Pfizer, Inc. Corporation Information

Table 101. Pfizer, Inc. Description and Business Overview

Table 102. Pfizer, Inc. Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 103. Pfizer, Inc. Ophthalmic Anti-infective Preparations Product

Table 104. Pfizer, Inc. Recent Developments/Updates

Table 105. Regeneron Pharmaceuticals, Inc. Corporation Information

Table 106. Regeneron Pharmaceuticals, Inc. Description and Business Overview

Table 107. Regeneron Pharmaceuticals, Inc. Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 108. Regeneron Pharmaceuticals, Inc. Ophthalmic Anti-infective Preparations Product

Table 109. Regeneron Pharmaceuticals, Inc. Recent Developments/Updates

Table 110. Santen Pharmaceuticals Co., Ltd. Corporation Information

Table 111. Santen Pharmaceuticals Co., Ltd. Description and Business Overview

Table 112. Santen Pharmaceuticals Co., Ltd. Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 113. Santen Pharmaceuticals Co., Ltd. Ophthalmic Anti-infective Preparations Product

Table 114. Santen Pharmaceuticals Co., Ltd. Recent Developments/Updates

Table 115. Shire PLC Corporation Information

Table 116. Shire PLC Description and Business Overview

Table 117. Shire PLC Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 118. Shire PLC Ophthalmic Anti-infective Preparations Product

Table 119. Shire PLC Recent Developments/Updates

Table 120. Bausch Health Corporation Information

Table 121. Bausch Health Description and Business Overview

Table 122. Bausch Health Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 123. Bausch Health Ophthalmic Anti-infective Preparations Product

Table 124. Bausch Health Recent Developments/Updates

Table 125. Lupin Pharmaceuticals Corporation Information

Table 126. Lupin Pharmaceuticals Description and Business Overview

Table 127. Lupin Pharmaceuticals Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 128. Lupin Pharmaceuticals Ophthalmic Anti-infective Preparations Product

Table 129. Lupin Pharmaceuticals Recent Developments/Updates

Table 130. Apotex Corporation Information

Table 131. Apotex Description and Business Overview

Table 132. Apotex Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 133. Apotex Ophthalmic Anti-infective Preparations Product

Table 134. Apotex Recent Developments/Updates

Table 135. Akorn Corporation Information

Table 136. Akorn Description and Business Overview

Table 137. Akorn Ophthalmic Anti-infective Preparations Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 138. Akorn Ophthalmic Anti-infective Preparations Product

Table 139. Akorn Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Ophthalmic Anti-infective Preparations Distributors List

Table 143. Ophthalmic Anti-infective Preparations Customers List

Table 144. Ophthalmic Anti-infective Preparations Market Trends

Table 145. Ophthalmic Anti-infective Preparations Market Drivers

Table 146. Ophthalmic Anti-infective Preparations Market Challenges

Table 147. Ophthalmic Anti-infective Preparations Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Ophthalmic Anti-infective Preparations

Figure 2. Global Ophthalmic Anti-infective Preparations Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Ophthalmic Anti-infective Preparations Market Share by Type in 2023 & 2030

Figure 4. Antibacterial Product Picture

Figure 5. Antiviral Product Picture

Figure 6. Antifungal Product Picture

Figure 7. Anti-parasitic Product Picture

Figure 8. Others Product Picture

Figure 9. Global Ophthalmic Anti-infective Preparations Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Ophthalmic Anti-infective Preparations Market Share by Application in 2023 & 2030

Figure 11. Hospital Use

Figure 12. Clinic Use

Figure 13. Household

Figure 14. Other

Figure 15. Global Ophthalmic Anti-infective Preparations Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Ophthalmic Anti-infective Preparations Market Size (2019-2030) & (US$ Million)

Figure 17. Global Ophthalmic Anti-infective Preparations Sales (2019-2030) & (MT)

Figure 18. Global Ophthalmic Anti-infective Preparations Average Price (USD/MT) & (2019-2030)

Figure 19. Ophthalmic Anti-infective Preparations Report Years Considered

Figure 20. Ophthalmic Anti-infective Preparations Sales Share by Manufacturers in 2023

Figure 21. Global Ophthalmic Anti-infective Preparations Revenue Share by Manufacturers in 2023

Figure 22. The Global 5 and 10 Largest Ophthalmic Anti-infective Preparations Players: Market Share by Revenue in 2023

Figure 23. Ophthalmic Anti-infective Preparations Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 24. Global Ophthalmic Anti-infective Preparations Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 25. North America Ophthalmic Anti-infective Preparations Sales Market Share by Country (2019-2030)

Figure 26. North America Ophthalmic Anti-infective Preparations Revenue Market Share by Country (2019-2030)

Figure 27. U.S. Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Canada Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Europe Ophthalmic Anti-infective Preparations Sales Market Share by Country (2019-2030)

Figure 30. Europe Ophthalmic Anti-infective Preparations Revenue Market Share by Country (2019-2030)

Figure 31. Germany Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. France Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. U.K. Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Italy Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Russia Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Asia Pacific Ophthalmic Anti-infective Preparations Sales Market Share by Region (2019-2030)

Figure 37. Asia Pacific Ophthalmic Anti-infective Preparations Revenue Market Share by Region (2019-2030)

Figure 38. China Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Japan Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. South Korea Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. India Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Australia Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Taiwan Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Indonesia Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Thailand Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Malaysia Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Philippines Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Latin America Ophthalmic Anti-infective Preparations Sales Market Share by Country (2019-2030)

Figure 49. Latin America Ophthalmic Anti-infective Preparations Revenue Market Share by Country (2019-2030)

Figure 50. Mexico Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Brazil Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Argentina Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Middle East & Africa Ophthalmic Anti-infective Preparations Sales Market Share by Country (2019-2030)

Figure 54. Middle East & Africa Ophthalmic Anti-infective Preparations Revenue Market Share by Country (2019-2030)

Figure 55. Turkey Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. UAE Ophthalmic Anti-infective Preparations Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. Global Sales Market Share of Ophthalmic Anti-infective Preparations by Type (2019-2030)

Figure 59. Global Revenue Market Share of Ophthalmic Anti-infective Preparations by Type (2019-2030)

Figure 60. Global Ophthalmic Anti-infective Preparations Price (USD/MT) by Type (2019-2030)

Figure 61. Global Sales Market Share of Ophthalmic Anti-infective Preparations by Application (2019-2030)

Figure 62. Global Revenue Market Share of Ophthalmic Anti-infective Preparations by Application (2019-2030)

Figure 63. Global Ophthalmic Anti-infective Preparations Price (USD/MT) by Application (2019-2030)

Figure 64. Ophthalmic Anti-infective Preparations Value Chain

Figure 65. Ophthalmic Anti-infective Preparations Production Process

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Distributors Profiles

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-31X2542

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

ELISA Technologies - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-6C4296

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

Blow-Fill-Seal (BFS) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-22N3952

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

Membrane Technology in Pharma, Biopharma, And Life Science - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-5A6999

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Ophthalmic Anti-infective Preparations Market Research Report 2024

Published Date: June 2024

Report Code: QYRE-Auto-24W7930

Global Ophthalmic Anti-infective Preparations Market Research Report 2024

FEATURED COMPANIES

Ophthalmic Anti-infective Preparations Market Size

Ophthalmic Anti-infective Preparations Market

Report Scope

Scope of Ophthalmic Anti-infective Preparations Market Report

Chapter Outline

FAQ for this report

How fast is Ophthalmic Anti-infective Preparations Market growing?

What is the Ophthalmic Anti-infective Preparations Market size in 2030?

Who are the main players in the Ophthalmic Anti-infective Preparations Market report?

What are the Application segmentation covered in the Ophthalmic Anti-infective Preparations Market report?

What are the Type segmentation covered in the Ophthalmic Anti-infective Preparations Market report?

FEATURED COMPANIES

RELATED REPORTS